Urinary excretion of podocytes in patients with diabetic nephropathy

Nephrology Dialysis Transplantation

Volumn 15, Issue 9, 2000, Pages 1379-1383

  Nakamura, Tsukasa ^a   Ushiyama, Chifuyu ^a   Suzuki, Shingo ^a   Hara, Masanori ^b   Shimada, Noriaki ^c   Ebihara, Isao ^c   Koide, Hikaru ^c  

^a Misato Junshin Hospital   (Japan)

^b Yoshida Hospital   (Japan)

^c KOTO HOSPITAL   (Japan)

Author keywords

Basement membrane; Epithelial cell; Extracellular matrix; Glomerulosclerosis; Microalbuminuria; Podocalyxin

Indexed keywords

ALBUMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GELATINASE B; MONOCLONAL ANTIBODY; PODOCALYXIN; TRANDOLAPRIL;

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE MARKER; FEMALE; HUMAN; IMMUNOFLUORESCENCE; MALE; MICROALBUMINURIA; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; URINARY EXCRETION;

EID: 0033833789     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.9.1379     Document Type: Article

References (25)

1. The role of the glomerular epithelial cell in the maintenance of the glomerular filtration barrier
2. Monoclonal antobodies to human glomerular cells: A marker for glomerular epithelial cells
3. Identification of a major sialoprotein in the glycocalyx of human visceral glomerular epithelial cells
4. Urinary excretion of podocalyxin indicates glomerular epithelial cell injuries in glomerulonephritis
5. Immunohistochemical and urinary markers of podocyte injury
6. Urinary excretion of podocytes reflects disease activity in children with glomerulonephritis
7. Human 92- and 72-kilodalton type IV collagenases are elastase
8. Matrix metalloproteinase-9 in human plasma has 96% specificity and 56% sensitivity for gastric cancer screening
9. Effect of cigarette smoking on plasma metalloproteinase-9 concentration
10. Elevation of serum levels of metalloproteinase-1, tissue inhibitor of metalloproteinase-1 and type IV collagen, and plasma levels of metalloproteinase-9 in polycystic kidney disease
11. Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus
12. ACE inhibitors and diabetic nephropathy: Clinical and experimental findings
13. Long-term renoprotective effect of angiotensin-converting enzyme inhibitor in non-insulin-dependent diabetes mellitus
14. Effective postponement of diabetic patients with microalbuminuria
15. A one-step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloproteinase-9 using monoclonal antibodies
16. Podocyte loss and progressive glomerular injury in type II diabetes
17. Alterations in the expression of the alpha 3 beta 1 integrin in certain membrane domains of the glomerular epithelial cells (podocytes) in diabetes mellitus
18. Microalbuminuria in essential hypertension
19. Podocyte number predicts long-term urinary albumin excretion in Pima Indians with type II diabetes and microalbuminuria
20. Endothelial dysfunction precedes development of microalbuminuria in IDDM
21. Characterization of a glomerular epithelial cell metalloproteinases as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy
22. Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients
23. Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats. Protective effects of ACE inhibition
24. Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy